Regulation of autophagy by TGF-β: Emerging role in kidney fibrosis

Seminars in Nephrology

Volumn 34, Issue 1, 2014, Pages 62-71

  Ding, Yan ^a,b   Choi, Mary E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Autophagy; Chronic kidney disease; Fibrosis; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

AUTOPHAGY; CHAPERONE-MEDIATED AUTOPHAGY; DIABETIC NEPHROPATHY; EPITHELIAL MESENCHYMAL TRANSITION; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; MESANGIUM; METABOLIC REGULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL PROTECTION; RENAL TUBULOINTERSTITIAL FIBROSIS; REVIEW; SIGNAL TRANSDUCTION;

AUTOPHAGY; CHRONIC KIDNEY DISEASE; FIBROSIS; TRANSFORMING GROWTH FACTOR-Β1;

ANIMALS; AUTOPHAGY; DIABETIC NEPHROPATHIES; FIBROSIS; HUMANS; KIDNEY; KIDNEY TUBULES; MESANGIAL CELLS; PROTEINURIA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84893378908     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2013.11.009     Document Type: Review

References (70)

1. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
2. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
3. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010, 90:1383-1435.
4. He C., Levine B. The Beclin 1 interactome. Curr Opin Cell Biol 2010, 22:140-149.
5. Böttinger E.P., Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002, 13:2600-2610.
6. Santibañez J.F., Quintanilla M., Bernabeu C. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011, 121:233-251.
7. Lyons R.M., Gentry L.E., Purchio A.F., Moses H.L. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 1990, 110:1361-1367.
8. Gerets H.H., Hanon E., Cornet M., Dhalluin S., Depelchin O., Canning M., et al. Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach. Toxicol In Vitro 2009, 23:319-332.
9. Wang W., Koka V., Lan H.Y. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005, 10:48-56.
10. Roberts A.B. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 1998, 24:111-119.
11. Derynck R., Zhang YE Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
12. Sanderson N., Factor V., Nagy P., Kopp J., Kondaiah P., Wakefield L., et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 1995, 92:2572-2576.
13. Kopp J.B., Factor V.M., Mozes M., Nagy P., Sanderson N., Böttinger E.P., et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996, 74:991-1003.
14. Border W.A., Noble N.A. Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int 1998, 54:1390-1391.
15. Uranova N., Bonartsev P., Brusov O., Morozova M., Rachmanova V., Orlovskaya D. The ultrastructure of lymphocytes in schizophrenia. World J Biol Psychiatry 2007, 8:30-37.
16. Edlund S., Landström M., Heldin C.H., Aspenström P. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 2002, 13:902-914.
17. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001, 12:27-36.
18. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000, 275:36803-36810.
19. Yi J.Y., Shin I., Arteaga C.L. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 2005, 280:10870-10876.
20. Wilkes M.C., Mitchell H., Penheiter S.G., Doré J.J., Suzuki K., Edens M., et al. Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 2005, 65:10431-10440.
21. Ding Y., Kim J.K., Kim S.I., Na H.J., Jun S.Y., Lee S.J., et al. TGF-{beta}1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem 2010, 285:37909-37919.
22. Hartsough M.T., Mulder K.M. Transforming growth factor activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 1995, 270:7117-7124.
23. Mucsi I., Skorecki K.L., Goldberg H.J. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression. J Biol Chem 1996, 271:16567-16572.
24. Atfi A., Djelloul S., Chastre E., Davis R., Gespach C. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem 1997, 272:1429-1432.
25. Hocevar B.A., Brown T.L., Howe P.H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 1999, 18:1345-1356.
26. Yue J., Sun B., Liu G., Mulder K.M. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor. J Cell Physiol 2004, 199:284-292.
27. Hanafusa H., Ninomiya-Tsuji J., Masuyama N., Nishita M., Fujisawa J., Shibuya H., et al. Involvement of the p38 mitogen activated protein kinase pathway in transforming growth factor beta-induced gene expression. J Biol Chem 1999, 274:27161-27167.
28. Chin B.Y., Mohsenin A., Li S.X., Choi A.M., Choi M.E. Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway. Am J Physiol Renal Physiol 2001, 280:F495-F504.
29. Wang L., Ma R., Flavell R.A., Choi M.E. Requirement of mitogen activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem 2002, 277:47257-47262.
30. Rodriguez-Barbero A., Obreo J., Yuste L., Montero J.C., Rodriguez- Pena A., Pandiella A., et al. Transforming growth factor beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. FEBS Lett 2002, 513:282-288.
31. Ono K., Ohtomo T., Ninomiya-Tsuji J., Tsuchiya M. A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta. Biochem Biophys Res Commun 2003, 307:332-337.
32. Kim S.I., Kwak J.H., Zachariah M., He Y., Wang L., Choi M.E. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am J Physiol Renal Physiol 2007, 292:F1471-F1478.
33. Hocevar B.A., Prunier C., Howe P.H. Disabled-2 (Dab2) mediates transforming growth factor (TGF)-stimulated fibronectin synthesis through TGF-activated kinase 1 and activation of the JNK pathway. J Biol Chem 2005, 280:25920-25927.
34. Choi M.E., Ding Y., Kim S.I. TGF-β signaling via TAK1 pathway: role in kidney fibrosis. Semin Nephrol 2012, 32:244-252.
35. Lan H.Y. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003, 12:25-29.
36. Grgic I., Duffield J.S., Humphreys B.D. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 2012, 27:183-193.
37. Gewin L., Zent R. How does TGF-β mediate tubulointerstitial fibrosis?. Semin Nephrol 2012, 32:228-235.
38. Gajewska M., Gajkowska B., Motyl T. Apoptosis and autophagy induced by TGF-B1 in bovine mammary epithelial BME-UV1 cells. J Physiol Pharmacol 2005, 56(Suppl 3):143-157.
39. Godlewski M.M., Hallay N., Bierła J.B., Zabielski R. Molecular mechanism of programmed cell death in the gut epithelium of neonatal piglets. J Physiol Pharmacol 2007, 58(Suppl 3):97-113.
40. Kiyono K., Suzuki H.I., Matsuyama H., Morishita Y., Komuro A., Kano M.R., et al. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res 2009, 69:8844-8852.
41. Suzuki H.I., Kiyono K., Miyazono K. Regulation of autophagy by transforming growth factor-β (TGF-β) signaling. Autophagy 2010, 6:645-647.
42. Kim S.I., Na H.J., Ding Y., Wang Z., Lee S.J., Choi M.E. Autophagy promotes intracellular degradation of type I collagen induced by transforming growth factor (TGF)-β1. J Biol Chem 2012, 287:11677-11688.
43. Wang L., Lee J.Y., Kwak J.H., He Y., Kim S.I., Choi M.E. Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction. Am J Physiol Renal Physiol 2008, 294:F508-F517.
44. Jiang M., Wei Q., Dong G., Komatsu M., Su Y., Dong Z. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 2012, 82:1271-1283.
45. Xu Y., Yang S., Huang J., Ruan S., Zheng Z., Lin J. Tgf-β1 induces autophagy and promotes apoptosis in renal tubular epithelial cells. Int J Mol Med 2012, 29:781-790.
46. Koesters R., Kaissling B., Lehir M., Picard N., Theilig F., Gebhardt R., et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010, 177:632-643.
47. Del Principe D., Lista P., Malorni W., Giammarioli A.M. Fibroblast autophagy in fibrotic disorders. J Pathol 2013, 229:208-220.
48. Hernández-Gea V., Ghiassi-Nejad Z., Rozenfeld R., Gordon R., Fiel M.I., Yue Z., et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 2012, 142:938-946.
49. Patel A.S., Lin L., Geyer A., Haspel J.A., An C.H., Cao J., et al. Autophagy in idiopathic pulmonary fibrosis. PLoS One 2012, 7:e41394.
50. Forbes M.S., Thornhill B.A., Chevalier R.L. Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: a new look at an old model. Am J Physiol Renal Physiol 2011, 301:F110-F117.
51. Forbes M.S., Thornhill B.A., Minor J.J., Gordon K.A., Galarreta C.I., Chevalier R.L. Fight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosis. Am J Physiol Renal Physiol 2012, 303:F120-F129.
52. Kim W.Y., Nam S.A., Song H.C., Ko J.S., Park S.H., Kim H.L., et al. The role of autophagy in unilateral ureteral obstruction rat model. Nephrology (Carlton) 2012, 17:148-159.
53. Li L., Zepeda-Orozco D., Black R., Lin F. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010, 176:1767-1778.
54. Xu Y., Ruan S., Wu X., Chen H., Zheng K., Fu B. Autophagy and apoptosis in tubular cells following unilateral ureteral obstruction are associated with mitochondrial oxidative stress. Int J Mol Med 2013, 31:628-636.
55. Chung S.D., Lai T.Y., Chien C.T., Yu H.J. Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney. PLoS One 2012, 7:e47299.
56. Pallet N., Bouvier N., Legendre C., Gilleron J., Codogno P., Beaune P., et al. Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy 2008, 4:783-791.
57. D'Agati V.D. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int 2008, 73:399-406.
58. Hartleben B., Gödel M., Meyer-Schwesinger C., Liu S., Ulrich T., Köbler S., et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010, 120:1084-1096.
59. Chen J., Chen M.X., Fogo A.B., Harris R.C., Chen J.K. mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J Am Soc Nephrol 2013, 24:198-207.
60. Tanaka Y., Kume S., Kitada M., Kanasaki K., Uzu T., Maegawa H., et al. Autophagy as a therapeutic target in diabetic nephropathy. Exp Diabetes Res 2012, 2012:628978.
61. Barbosa Júnior Ade A., Zhou H., Hültenschmidt D., Totovic V., Jurilj N., Pfeifer U. Inhibition of cellular autophagy in proximal tubular cells of the kidney in streptozotocin-diabetic and uninephrectomized rats. Virchows Arch B Cell Pathol Incl Mol Pathol 1992, 61:359-366.
62. Han K., Zhou H., Pfeifer U. Inhibition and restimulation by insulin of cellular autophagy in distal tubular cells of the kidney in early diabetic rats. Kidney Blood Press Res 1997, 20:258-263.
63. Vallon V., Rose M., Gerasimova M., Satriano J., Platt K.A., Koepsell H., et al. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol 2013, 304:F156-F167.
64. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
65. Sooparb S., Price S.R., Shaoguang J., Franch H.A. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 2004, 65:2135-2144.
66. Kitada M., Kume S., Takeda-Watanabe A., Kanasaki K., Koya D. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond) 2013, 124:153-164.
67. Kitada M., Takeda A., Nagai T., Ito H., Kanasaki K., Koya D. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res 2011, 2011:908185.
68. Guerrot D., Dussaule J.C., Kavvadas P., Boffa J.J., Chadjichristos C.E., Chatziantoniou C. Progression of renal fibrosis: the underestimated role of endothelial alterations. Fibrogenesis Tissue Repair 2012, 5(Suppl 1):S15.
69. Shangguan L., Ti X., Krause U., Hai B., Zhao Y., Yang Z., et al. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Stem Cells 2012, 30:2810-2819.
70. Xavier S., Gilbert V., Rastaldi M.P., Krick S., Kollins D., Reddy A., et al. BAMBI is expressed in endothelial cells and is regulated by lysosomal/autolysosomal degradation. PLoS One 2010, 5:e12995.